Cargando…
Immune Response to COVID-19 Vaccination in Hematologic Malignancies: A Mini-Review
The outbreak of the COVID-19 infection has led to the rapidity of vaccine usage in recent years. Emerging data indicate that the efficacy of vaccination against COVID-19 was about 95% in the general population, though its impact is impaired in patients with hematologic malignancies. As such, we deci...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Chonnam National University Medical School
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900228/ https://www.ncbi.nlm.nih.gov/pubmed/36794237 http://dx.doi.org/10.4068/cmj.2023.59.1.24 |